ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Innovations in Extracellular Vesicles Research Conference 2025: Focus on Technologies, Tools, Demos & Applications (California, United States - November 19, 2025) - ResearchAndMarkets.com

The "Innovations in Extracellular Vesicles Research 2025: Technologies, Tools, Demos & Applications" conference has been added to ResearchAndMarkets.com's offering.

The Innovations in Extracellular Vesicles 2025: Technologies, Tools, Demos & Applications is designed to highlight the instruments and reagent platforms that are continually being developed by companies to drive research in the Extracellular Vesicles (EVs) field.

This conference comprises of scientific presentations, technical presentations by platform developers, hands-on demos performed onsite at The Slate Room by companies, plus scientific round-table discussions, exhibitors and extensive networking opportunities across the 2.5-day conference.

There are ample opportunities for networking, partnering and business development and this ensures a very cost-effective conference trip. The Exhibit Hall is Co-Located with the Conference Tracks for Excellent Networking and The Slate Room is Co-Located for companies to conduct product/instrument demos onsite at the conference.

All participants receive full access to both co-located conferences for maximal scientific exchange and networking:

  • Lab-on-a-Chip and Microfluidics World Congress 2025
  • Innovations in Extracellular Vesicles 2025: Technologies, Tools, Demos & Applications

Agenda:

  • Flow Cytometry Platforms for Studying Extracellular Vesicles (EVs)
  • Single EV Analysis
  • Biological Studies Possible Using Single EV Analysis
  • Nanoparticle Tracking (NT) and Its Utilization in EV Research
  • Advances in NT Technology
  • Emerging EV Research Areas
  • Novel Reagents and Tools for EV Analysis
  • EV Studies Using Microfluidics Tools

Speakers

  • Daniel Chiu, A. Bruce Montgomery Professor of Chemistry, University of Washington
  • Sven Kreutel, CEO, Particle Metrix, Inc.
  • Danilo Tagle, Director, Office of Special Initiatives, National Center for Advancing Translational Sciences at the NIH (NCATS)
  • Steve Soper, Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas

For more information about this conference visit https://www.researchandmarkets.com/r/1hyqvf

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.